Giiant Pharma hires new VP of Discovery & Chemistry
10 September 2021 -

Montreal biotech company Giiant Pharma Inc revealed on Thursday the election of Christophe Mellon, PhD as vice president of its Discovery & Chemistry.

As part of the management team, Dr Mellon will make a true impact on the company's technology platform for the development of novel patient-tailored GI therapies, said its CEO Maxime Ranger.

Recently, Dr Mellon had been appointed to lead a company in the material science industry as well as holding leadership positions in pharmaceutical, biotech and start-up companies for more than 20 years.

Dr Mellon is a medicinal chemist with a proven track record in entrepreneurship, as a technology inventor, investor and board member. He holds a PhD from the University of Montreal as well as a post-doctorate from MIT, concluded the company.